Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion. (2017)
Attributed to:
New non-paralytic botulinum molecules for the control of pain
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-017-05948-z
PubMed Identifier: 28729700
Publication URI: http://europepmc.org/abstract/MED/28729700
Type: Journal Article/Review
Volume: 7
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322